Stocks · US
UTHR
XNAS
United Therapeutics Corp
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E17.55x
P/B3.59x
P/S7.29x
EPS$30.56
ROE20.48%
ROA18.16%
Dividend yield0.00%
EV/EBITDA14.20x
Debt/Equity0.00
Free cash flow$1.1B
Returns and 52-week range
1W+12.49%
1M+11.08%
3M-2.29%
6M-4.26%
1Y+19.54%
YTD+9.04%
52W high$609.35
52W low$409.07
From 52W high-11.12%
Company
Peers in the same sector
| Company | Market cap | P/E | P/B | 1M |
|---|---|---|---|---|
| Incyte Genomics Inc | $23.1B | 14.35 | 3.65 | -11.06% |
| Insmed, Inc. | $22.7B | — | 29.93 | -16.68% |
| 랩코프 | $25.0B | 24.97 | 2.91 | -4.64% |
| Tenet Healthcare Corporation New | $20.9B | 9.32 | 4.49 | -2.48% |
| 가단트 헬스 | $25.1B | — | — | +5.75% |
| STERIS plc | $20.6B | 25.56 | 2.86 | -7.10% |
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.